SCHEMBL4380283

SCHEMBL4380283

CCC(C(=O)OC)c1cc(OCc2ccccc2)cc(OCc2ccccc2)c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.42
CTSK P43235 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 1/20 0.41
PPARG P37231 2/20 0.41
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SGMS2 Q8NHU3 2/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381588 0.92 FFAR1 (0.42) LTA4HCTSKPPARGLMNAL3MBTL1
SCHEMBL4383176 0.90 PSEN1 (0.44) MEN1KMT2AKDM4EPPARGLMNA
SCHEMBL4380219 0.85 LTA4H (0.43) LTA4HMEN1KMT2ANPC1RAB9A
SCHEMBL4379885 0.85 EGFR (0.40) NPC1RAB9ASMN1; SMN2KDM4EGAA
SCHEMBL4380779 0.80 TDP1 (0.42) NPC1RAB9ASMN1; SMN2KDM4EGAA
SCHEMBL4393860 0.79 CAPN1 (0.46) MEN1KMT2ARAB9AGAAPPARG
SCHEMBL4379734 0.78 KDR (0.35) KDM4EMAPTHPGD
SCHEMBL4379314 0.77 RXRA (0.37) GAAMAPT
SCHEMBL4385029 0.75 AKR1C3 (0.41) SMN1; SMN2KDM4ELMNAL3MBTL1MAPT
SCHEMBL4380947 0.75 CNR2 (0.42) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P LTA4H 4672/4885CTSK 4129/4885MEN1 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.